Table 5.
Author | ML Algorithms | Prediction Target | Key Predictive Factors | Main Results/Performance Metrics | Model Validation & Interpretability | Other Important Findings |
---|---|---|---|---|---|---|
Ren 2023 [59] | CatBoost, SVM, RF, LR | LTP | Number of tumors, Albumin, AFP, Tumor size, Age, INR | Best performance by CatBoost model, AUC of 0.898 | Internal and external validation | NA |
An 2022 [60] | LR, RF, SVM, XGBoost | ER | Tumor number, Platelets, AFP, Comorbidity score, WBC, ChE, PT, Neutrophils, Etiology | Best performance by XGBoost model, AUC 0.74 (internal) and 0.76 (external) | Internal and external validation, SHAP and LIME algorithms for model explanation | NA |
Shahveranova 2023 [61] | LR | LTP | Preoperative extrahepatic metastasis, Tumor size, CA 19-9 | Combined Model 2 (clinical data and Phase 2 radiomic features) has the highest discriminative performance for LTP prediction (AUC 0.981) | NA | LTP group patients have significantly higher radiomic scores in both MRI phases (Phase 1 and Phase 2) |
CatBoost: A machine learning algorithm based on decision trees; LTP: Local Tumor Progression; INR: International Normalized Ratio; ER: Early Recurrence; ChE: Cholinesterase; PT: Prothrombin Time; WBC: White Blood Cell Count; CRLM: Colorectal Liver Metastasis; CA 19-9: A tumor marker for gastrointestinal malignancies; LIME: Local Interpretable Model-agnostic Explanations; AFP: Alpha-Fetoprotein.